Search Results - "Scanni, A"

Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer by Garassino, M.C., Marabese, M., Rusconi, P., Rulli, E., Martelli, O., Farina, G., Scanni, A., Broggini, M.

Get full text

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial by Mustacchi, G., Ceccherini, R., Milani, S., Pluchinotta, A., De Matteis, A., Maiorino, L., Farris, A., Scanni, A., Sasso, F.

“…Background: To evaluate the efficacy of tamoxifen as primary treatment in women aged over 70 years with operable breast cancer versus surgery followed by…”
Get full text

Complications of subcutaneous infusion port in the general oncology population by Ballarini, C, Intra, M, Pisani Ceretti, A, Cordovana, A, Pagani, M, Farina, G, Perrone, S, Tomirotti, M, Scanni, A, Spina, G P

“…Subcutaneous infusion ports (SIPs) represent a valid method for long-term chemotherapy. The SIPs have several advantages over other methods of venous access:…”
Get more information

Reversible palpebral ptosis following oxaliplatin infusion by La Verde, N, Garassino, M.C, Spinelli, G, Scanni, A, Sburlati, P, Farina, G, Labianca, R

Get full text

Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study by Ardizzoia, A, Acquati, M, Fagnani, D, Giordano, M, Visini, M, Scanni, A, Quattrone, A, Fusco, O, Vergani, C, Casartelli, C, Tagliabue, P, Malugani, F

“…Docetaxel is one of the most active drugs in second-line therapy for non-small-cell-lung-carcinoma (NSCLC). The aim of this multicenter study was to evaluate…”
Get full text

Photoluminescence analysis on Teflon bulk and Teflon–like films grown by Ion-beam sputtering by Scanni, A, Valentini, A, Perna, G, Capozzi, V, Convertino, A

“…We have investigated the photoluminescence of Teflon-like films obtained by ion-beam sputtering. We show that Teflon material used for the target contains π-C…”
Get full text

Efficacy and tolerability of nasally administered compared to parenterally administered metoclopramide in the symptomatic treatment of chemotherapy-induced emesis in cancer outpatients. A controlled clinical study by Tomirotti, M, Dimaiuta, M, Confalonieri, M, Scanni, A

“…The clinical efficacy and tolerability of a new nasal spray formulation of metoclopramide (MTC) was evaluated in terms of its ability to prevent the nausea and…”
Get full text

Long Term Toxicity in Adjuvant Treatment with Tamoxifen by Cobelli, S., Dambrosio, M., Farina, G., Rovej, R., Tomirotti, M., Scanni, A.

“…Long term treatment with tamoxifen has produced few side effects, which are generally mild. Of the serious ones, all of them except eye toxicity seem to be…”
Get full text

Cis/Carboplatin + Vinorelbine +/- Radiotherapy in Stage III and IV Non Small Cell Lung Carcinoma by Tomirotti, M., Galassi, B., Dambrosio, M., Fossati, V., Gramegna, G., Colombo, F., Rovej, R., Scanni, A.

“…The aim of this study was the retrospective evaluation of the effectiveness of cis/carbo-platin + vinorelbine +/- radiotherapy in 118 patients with advanced…”
Get full text

Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer by Spinazzi, A, Soresi, E, Boffi, R, Nonis, A, Noseda, A, Cobelli, S, Scanni, A

“…Serum neuron-specific enolase (NSE), tissue polypeptide antigen (TPA), and carcinoembryonic antigen (CEA) were measured in 60 patients with small-cell lung…”
Get more information

Effect of tumor-specific KRAS mutational status on impact of anti-EGFR therapy in non-small cell lung cancer (NSCLC) by Garassino, M. C., Marabese, M., Broggini, M., Lauricella, C., Floriani, I., Martelli, O., Marsoni, S., Gherardi, G., Farina, G., Scanni, A.

“…Abstract only…”
Get full text

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group by Boccardo, F, Rubagotti, A, Bruzzi, P, Cappellini, M, Isola, G, Nenci, I, Piffanelli, A, Scanni, A, Sismondi, P, Santi, L

“…Between November 1, 1983 and June 30, 1987, 510 node-positive, estrogen receptor (ER)-positive breast cancer patients have been randomly allocated to receive…”
Get more information

Prevention of chemo-induced cardiotoxicity by dexrazoxane (D) by Tomirotti, M., Borgonovo, K., Ratti, R., Farina, G., Scanni, A.

“…Abstract only…”
Get full text

Role of k-ras mutations in patients affected with NSCLC and treated with tyrosine kinase inhibitors (tkis): Results of a pooled analysis by Martelli, O., Farina, G., Garassino, M. C., Mancuso, A., Gambacorta, M., Gherardi, G., Bianchi, F., Floriani, I., Torrri, V., Scanni, A.

“…Abstract only…”
Get full text

Intranasal Metoclopramide: A Viewpoint by Alberto Scanni by Scanni, Alberto

Get full text

Concurrent carboplatin (CBDCA), vindesine (VDS) and radiotherapy in stage III non small cell lung cancer (NSCLC) by Tomirotti, M, Gramegna, G, Mantellini, P, Fossati, V, Mezzetti, M, Dimaiuta, M, Scanni, A

“…Aim of the study was to test, in a cooperative and prospective trial, the effectiveness and feasibility of a chemoradio-therapy program in stage III non small…”
Get more information

Antithrombotic prophylaxis (AP) and catether-related infections in cancer patients (pts) carrying central venous devices (CVD): An observational study by Fagnani, D., Franchi, R., Porta, C., Giordano, M., Scanni, A., Bertolini, A., Duro, M., Ardizzoia, A., Filipazzi, V., Cimminiello, C.

“…Abstract only 18550 Background: Recent data underline the possibility to reduce catheter-related infections in cancer pts having placed a central line by using…”
Get full text

Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial by Tomirotti, M, Perrone, S, Giè, P, Canaletti, R, Carpi, A, Biasoli, R, Lombardi, F, Giovanninetti, A, Mensi, F, Villa, S

“…In 1982 a randomized trial was started to compare a cisplatin-containing polychemotherapy (CAP: cyclophosphamide - CPA 750 mg/m2, adriamycin - ADM 50 mg/m2,…”
Get more information

Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen by Mattioli, Rodolfo, Gridelli, Cesare, Castellanos, Javier, Duque, Antonio, Falcone, Alfredo, Mansutti, Mauro, Bacon, Pam, Lawrinson, Sue, Skacel, Tomas, Belon, J., Estévez, L., Mata, J., Scanni, A., Casas, Ana

“…Aim In several commonly used regimens, chemotherapy doses are split across different days of the cycle. We aimed to determine the feasibility of growth factor…”
Get full text

Registro central venous devices (CVD) - Polonord by Aondio, G., Fagnani, D., Porta, C., Bertolini, A., Giordano, M., Scanni, A., Ardizzoia, A., Franchi, R., Cimminiello, C.

“…Abstract only…”
Get full text